Overview

A Study to Evaluate the Efficacy and Safety of Pregabalin (Lyrica) for the Treatment of Nerve Pain

Status:
Completed
Trial end date:
2005-03-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to evaluate the efficacy and safety of Lyrica in Indian patients with nerve pain
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Pfizer
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Treatments:
Pregabalin
Criteria
Inclusion criteria:

- Peripheral neuropathic pain

- Score of at least 40 mm on the VAS of the SF-MPQ at screening and baseline

- Completion of at least 4 daily pain diary entries with an average daily pain score of
at least 4 over the 7 days prior to baseline

Exclusion criteria:

(none)